Heart Disease
FDA Updates: Moderna COVID-19 Vaccine EUA Caps Busy Week
Serious adverse events (AEs) occurred in 12% of patients; fatal and non-fatal heart attack and stroke were reported in 2.7% of patients taking the drug.
Serious adverse events (AEs) occurred in 12% of patients; fatal and non-fatal heart attack and stroke were reported in 2.7% of patients taking the drug.
/cloudfront-us-east-1.images.arcpublishing.com/dmn/P4FYQ4EF25DQJGJVCEKCPD6QD4.jpg)